{
    "clinical_study": {
        "@rank": "11643", 
        "arm_group": [
            {
                "arm_group_label": "Moxibustion treatment group", 
                "arm_group_type": "Experimental", 
                "description": "Apply traditional acupuncture to prevent the dysmenorrhea according to traditional Chinese medicine theory"
            }, 
            {
                "arm_group_label": "Medicine control group", 
                "arm_group_type": "Active Comparator", 
                "description": "Ibuprofen Sustained Release Capsules will be penetrated for dysmenorrhea"
            }
        ], 
        "brief_summary": {
            "textblock": "Hypothesis: Moxibustion is effective for managing primary dysmenorrhea. Aim: To attest the\n      effectiveness and safety of moxibustion for primary dysmenorrhea. Design: A randomized\n      controlled trial. 152 participants will be included. Two arms: moxibustion treatment group\n      and ibuprofen control group."
        }, 
        "brief_title": "Moxibustion for Primary Dysmenorrhea", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Primary Dysmenorrhea", 
        "condition_browse": {
            "mesh_term": "Dysmenorrhea"
        }, 
        "detailed_description": {
            "textblock": "There is no convincing evidence for the efficacy of moxibustion for primary dysmenorrhea,\n      due to low methodologic quality and small sample size. The investigators designed the random\n      clinical trial to investigates the effectiveness of moxibustion in treating primary\n      dysmenorrhea, the purpose of this study is to provide the research base of moxibustion\n      efficacy. The investigators also examined the acceptability and any adverse effects\n      associated with the use of moxibustion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of Guidelines of Primary dysmenorrhea clinical by the Society of\n             Obstetricians and Gynaecologists of Canada\n\n          -  Menstrual cycle is regular (28\u00b17) days\n\n          -  Syndrome differentiation of Traditional Chinese Medicine: Congealing cold-damp and\n             Qi-stagnation and blood stasis\n\n          -  Mean value of \u226540mm during last 3 months\n\n          -  Informed consent form must be signed by patient or lineal relative\n\n        Exclusion Criteria:\n\n          -  Patients with secondary dysmenorrhea, which is caused by endometriosis, pelvic\n             inflammation, myoma of uterus and so on\n\n          -  Patients who are unconscious and psychotic\n\n          -  Patients with serious primary illness or diseases of cardiovascular, liver, renal,\n             gastrointestinal, hematological systems and so on\n\n          -  Patients take prostaglandin synthetase inhibitors (PGSI) 2 weeks before inclusion\n\n          -  Pregnant women or women in lactation"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": {
            "#text": "152", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01972906", 
            "org_study_id": "2011SZ0302"
        }, 
        "intervention": [
            {
                "arm_group_label": "Moxibustion treatment group", 
                "description": "apply moxibustion according to traditional Chinese medicine", 
                "intervention_name": "moxibustion", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Medicine control group", 
                "description": "apply Ibuprofen (H20013062), 0.3g\uff0c Bid, lasting 3 days before menstrual cycle", 
                "intervention_name": "Ibuprofen Sustained Release Capsules", 
                "intervention_type": "Drug", 
                "other_name": "Fenbid"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ibuprofen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "moxibustion", 
            "primary dysmenorrhea"
        ], 
        "lastchanged_date": "October 25, 2013", 
        "location": {
            "contact": {
                "email": "cjthz@126.com", 
                "last_name": "Jiao Chen, master", 
                "phone": "13518189624"
            }, 
            "facility": {
                "address": {
                    "city": "Chengdu", 
                    "country": "China", 
                    "state": "Sichuan", 
                    "zip": "610072"
                }, 
                "name": "Affiliated hospital of Chengdu University of TCM"
            }, 
            "investigator": {
                "last_name": "LinNa Bo, master", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Traditional Chinese Moxibustion for Primary Dysmenorrhea", 
        "overall_contact": {
            "email": "jenny_yang_jie@126.com", 
            "last_name": "Jie Yang, PHD", 
            "phone": "13882296714"
        }, 
        "overall_official": {
            "affiliation": "Chengdu University of TCM", 
            "last_name": "Fanrong Liang, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Science and Technology Department of Sichuan Province", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "to assess the degree of dysmenorrhea", 
            "measure": "change from baseline in menstrual pain intensity measured by VAS at 6 months", 
            "safety_issue": "Yes", 
            "time_frame": "at baseline, 1st, 2nd, 3rd, 4th, 5th, 6th menstrual cycle after inclusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01972906"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "prostaglandin (PGF2a\u3001PGE2)", 
                "measure": "Laboratory index-1", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline, 4th  menstrual cycle  after inclusion"
            }, 
            {
                "description": "to assess the change of symptom during menstrual cycle", 
                "measure": "Cox Menstrual Symptom Scale  Cox Menstrual Symptom Scale", 
                "safety_issue": "Yes", 
                "time_frame": "1st, 2nd, 3rd, 4th, 5th, 6th, 7th menstrual cycle after inclusion"
            }, 
            {
                "description": "oxytocin", 
                "measure": "Laboratory Index-2", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline, 4 menstrual cycles after inclusion"
            }, 
            {
                "description": "\u03b2-endorphin", 
                "measure": "Laboratory Index-3", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline, 4 menstrual cycles after inclusion"
            }, 
            {
                "description": "plasma endothelin-1", 
                "measure": "Laboratory Index-4", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline, 4 menstrual cycles after inclucion"
            }, 
            {
                "description": "nitric oxide", 
                "measure": "Laboratory Index-5", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline, 4 menstrual cycles after inclusion"
            }, 
            {
                "description": "Plasma vascular pseudohemophilia factors", 
                "measure": "Laboratory Index-6", 
                "safety_issue": "Yes", 
                "time_frame": "at baseline, 4 menstrual cycles after inclusion"
            }
        ], 
        "source": "Chengdu University of Traditional Chinese Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chengdu University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}